Summary
Overview
Work History
Education
Timeline
Generic

Denise Lazarus

Golden

Summary

Proven track record of success as a Field Reimbursement Manager, Thought Leader, Clinical Trial Site and Academic Center Liaison, and Biopharmaceutical Account Executive within specialty therapy and rare disease markets.

Experienced in working with specialty pharmacies such as Panther, Accredo, and CuraScript, supporting both direct-to-consumer and hospital-based injectables—including calcium channel blockers, anti-thrombotics used in cardiac cath labs, intrathecal therapies, and buy-and-bill products.

Successfully led multiple product launches across rare disease, specialty, and hospital-based injectables and biologic's in cardiometabolic, endocrine, and neurology markets, achieving strong hospital formulary acceptance.

Held key roles on business strategy, sales, and brand marketing committees; served as a national and field trainer; and completed a marketing preceptorship. Additional experience includes co-ownership of a marketing firm and serving as Corporate Product Research & Development Manager.

Overview

32
32
years of professional experience

Work History

Associate Director, Rare Disease Account Manager & Field Reimbursement Manager

Ionis Pharmaceuticals
07.2024 - Current
  • Launched Tryngolza (Familia Chylomicronemia Syndrome-SP Distribution)
  • Drive patient access by partnering with healthcare provider offices to navigate reimbursement, coverage and product access pathways. Collaborate cross-functionally with market access, specialty pharmacy, patient support, and compliance teams to ensure payer coverage and timely therapy initiation.
  • Deliver disease education and introduce new diagnostic tools and clinical resources to support provider awareness and FCS diagnosis, strengthening relationships with office staff and decision-makers.
  • Genetic Test Team Lead and Member, Product Marketing Team

Rare Disease Area Development Manager

Rhythm Pharmaceuticals
01.2021 - 01.2024
  • Collaborated with cross functional teams, including commercial, medical science, clinical operations, and external partners, to optimize study site activations, enhanced patient recruitment, disease education, and expanded Rhythm’s genetic testing program and market presence.
  • Worked on Rhythm’s medical team to raise awareness for rare genetic diseases of obesity, promoted genetic testing, engaged with KOLs and site investigators, served as clinical trial site liaison and facilitated patient recruitment for clinical trials.
  • Marketing Preceptorship and ADM Team Marketing and Congress Leads

Rare Disease Account Executive

Biogen
01.2019 - 01.2021
  • Led SPINRAZA (intrathecal injection for SMA-SP distribution) sales and account management, formulary placement, development of sites of care, and promotion of Invitae genetic testing.
  • Facilitated procurement decisions and eliminated access barriers through collaborative efforts with internal and external stakeholders, including Accredo and CuraScript.
  • Served as RDAE Lead and SMA Trainer for Definitive Health Care ICD 9/ICD 10 code search.
  • Completed Biogen Access Academy. Recipient of the Fearless, Peer Choice and Community Achiever Award

Executive Area Business Manager

Acorda Therapeutics
01.2010 - 01.2019
  • Launched Inbrija, (Parkinson’s management inhalant-SP distribution) , Ampyra (an oral biologic for MS-SP distribution) and pain patch (buy and bill).
  • Managed product procurement across various healthcare facilities, including specialty pharmacies, infusion centers, V.A. Regional MS Sites of Excellence and outpatient rehabilitation hospitals.
  • Developed regional thought leader relationships to advocate with state and regional payers.
  • Promoted to Senior and Executive Business Manager, Run Through the Warehouse Contest Winner, Two-time Winner’s Circle Award Executive Sales Advisory and Marketing Advisory Boards.

Critical Care Account Specialist & National Field Trainer

The Medicines Company
01.2002 - 01.2010
  • Launched Cleviprex (CCB used in OR) and Angiomax (anti-thrombotic used in Cath Lab) injectables.
  • Engaged with surgeons, anesthesiologist, cardiologists, ICU/PACU critical care staff, and pharmacists to facilitate direct sales and obtain account formulary approval of Angiomax and Cleviprex.
  • Provided economic account analysis for Angiomax and Cleviprex.
  • Launched Angiomax and Cleviprex in CO/WY markets, securing formulary approvals across the board.
  • Developed treatment protocols for Cleviprex and Angiomax STEMI, sheath pull, OR and Post-Op.
  • Regional Field Trainer for the Western Region and Corporate Team Lead
  • Served as Interim Manager for The Western Region

Territory Business Manager

Bristol-Myers Squibb
01.1999 - 01.2002
  • Launched Plavix (an antiplatelet) and promoted Pravachol (lipid lowering medication).
  • Developed portfolio sales budget and business plans for Denver West Territory.
  • Recipient of the Pinnacle and Achievement and Excellence Award

Cardiovascular Medical Representative

Abbott Laboratories
01.1998 - 01.1999
  • Launched Tricor (triglyceride lowering medication).
  • Responsible for the development of key physician advocates for physician-to-physician teaching.

Marketing Research and Development Manager

Farm Stores
01.1995 - 01.1998
  • Developed and executed successful marketing strategic plans for brand products and retail organization with external marketing agencies to drive brand awareness, market share and revenue growth.
  • Supervised multiple external agencies, oversaw advertising production, and ensured delivery of brand-aligned promotional content.

Co-Owner Founder-Marketing and Sales Firm

Advanced Matrix, Inc.
01.1994 - 01.1995
  • Led strategic marketing planning and execution for healthcare and public sector clients, including Safety-Derm, one of the early antimicrobial product introduced in the U.S. for institutional use.
  • Oversaw brand messaging, media strategy, and cross-channel campaign execution.
  • Managed marketing budget and planning oversight, developing strategic marketing plans for AMI clients.

Education

B.A. Degree - Public Communications

The American University
Washington, DC

Timeline

Associate Director, Rare Disease Account Manager & Field Reimbursement Manager

Ionis Pharmaceuticals
07.2024 - Current

Rare Disease Area Development Manager

Rhythm Pharmaceuticals
01.2021 - 01.2024

Rare Disease Account Executive

Biogen
01.2019 - 01.2021

Executive Area Business Manager

Acorda Therapeutics
01.2010 - 01.2019

Critical Care Account Specialist & National Field Trainer

The Medicines Company
01.2002 - 01.2010

Territory Business Manager

Bristol-Myers Squibb
01.1999 - 01.2002

Cardiovascular Medical Representative

Abbott Laboratories
01.1998 - 01.1999

Marketing Research and Development Manager

Farm Stores
01.1995 - 01.1998

Co-Owner Founder-Marketing and Sales Firm

Advanced Matrix, Inc.
01.1994 - 01.1995

B.A. Degree - Public Communications

The American University
Denise Lazarus